Article
Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.
Blood transfusion = Trasfusione del sangue - 14 Nov 2023
Isakson Pauline, Pardi Cecilia
Abstract excerpt
BACKGROUND: RhD immunization is still the major cause of hemolytic disease of the fetus and newborn. Fetal RHD genotyping during pregnancy followed by tailored anti-D prophylaxis for pregnant RhD-negative women carrying an RHD-positive fetus to prevent RhD immunization is a well-established practice in many countries. This study aimed to validate a platform for high-throughput, non-invasive, single-exon, fetal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
